Kolexia
Fantin Bruno Médecine interne
Fantin Bruno
Médecine interne
Hôpital Beaujon
Clichy, France
192 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à Escherichia coli Bactériémie Abcès Maladie de Gaucher Abcès du foie Péritonite Sepsie Angiocholite Méningite

Collaborateurs

Voir plus
De Lastours Victoire
De Lastours Victoire
Hôpital Beaujon, Clichy, France
Lefort Agnes
Lefort Agnes
Ghu Paris Site Henry Ey, Paris, France
Zarrouk Virginie
Zarrouk Virginie
Hôpital Beaujon, Clichy, France
Leflon-Guibout Veronique
Leflon-Guibout Veronique
Hôpital Beaujon, Clichy, France

Industries

Voir plus
A+A
2 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.
The Lancet. Infectious diseases   17 janvier 2024
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
The Journal of antimicrobial chemotherapy   06 septembre 2023
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses.
Mycoses   03 août 2023
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
International journal of antimicrobial agents   10 juin 2023
Enterococcal pyogenic liver abscesses: high risk of treatment failure and mortality.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   04 janvier 2023
Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant , In Vitro and in a Murine Peritonitis Model.
Antibiotics (Basel, Switzerland)   03 janvier 2023
Clinical and microbiological characteristics of reflux cholangitis following bilio-enteric anastomosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   18 juillet 2022
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Infection   22 mars 2022
Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
The Journal of antimicrobial chemotherapy   03 mars 2022
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment.
International journal of medical microbiology : IJMM   04 janvier 2022